{{Rsnum
|rsid=3760776
|Gene=FUT6
|Chromosome=19
|position=5839735
|Orientation=minus
|GMAF=0.2098
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FUT6
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 21.2 | 0.0
| HCB | 75.2 | 23.4 | 1.5
| JPT | 80.5 | 18.6 | 0.9
| YRI | 22.4 | 49.7 | 27.9
| ASW | 22.8 | 42.1 | 35.1
| CHB | 75.2 | 23.4 | 1.5
| CHD | 65.1 | 33.0 | 1.8
| GIH | 71.0 | 27.0 | 2.0
| LWK | 19.1 | 48.2 | 32.7
| MEX | 86.2 | 13.8 | 0.0
| MKK | 44.9 | 42.9 | 12.2
| TSI | 71.6 | 24.5 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21203500
|Trait=None
|Title=Genomics Meets Glycomics-The First GWAS Study of Human N-Glycome Identifies HNF1± as a Master Regulator of Plasma Protein Fucosylation
|RiskAllele=A
|Pval=1E-12
|OR=0.3400
|ORtxt=[0.24-0.44] unit decrease
|OA=1
}}

{{PMID Auto GWAS
|PMID=22367966
|Trait=None
|Title=Genome-wide association study identifies novel loci associated with serum level of vitamin B12 in Chinese men.
|RiskAllele=
|Pval=4E-13
|OR=49.7800
|ORtxt=None
}}

{{PMID Auto GWAS
  |PMID=23300138
  |Trait=Tumor biomarkers
  |Title=A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
  |RiskAllele=T
  |Pval=2E-56
  |OR=.17
  |ORtxt=[0.11-0.22] U/ml decrease
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}